SCHEMBL29379363

SCHEMBL29379363

FCCn1ccc2ccccc21

nearest known ligand 0.76

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 5/20 0.76
CCND1 P24385 5/20 0.76
HTR2A P28223 1/20 0.59
HTR2C P28335 1/20 0.59
LMNA P02545 1/20 0.56
KMT2A Q03164 1/20 0.52
MAPK1 P28482 2/20 0.51
HTT P42858 1/20 0.51
ALDH1A1 P00352 1/20 0.49
HTR6 P50406 1/20 0.49
MTNR1A P48039 1/20 0.48
MTNR1B P49286 1/20 0.48
DAO P14920 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17822342 1.00 CDK4 (0.76) CDK4CCND1HTR2AHTR2CLMNA
SCHEMBL11366447 0.87 CDK4 (1.00) CDK4CCND1HTR2AHTR2CLMNA
SCHEMBL28616424 0.85 CDK4 (0.82) CDK4CCND1HTR2AHTR2CLMNA
SCHEMBL1120445 0.83 CDK4 (0.76) CDK4CCND1HTR2AHTR2CLMNA
SCHEMBL6125407 0.83 CDK4 (0.68) CDK4CCND1HTR2AHTR2CLMNA
Hydrochloric Acid SCHEMBL6258190 0.82 CDK4 (0.73) CDK4CCND1HTR2AHTR2CLMNA
SCHEMBL135070 0.80 CDK4 (0.78) CDK4CCND1HTR2AHTR2CLMNA
SCHEMBL3347874 0.79 CDK4 (0.76) CDK4CCND1HTR2AHTR2CLMNA
SCHEMBL3134501 0.79 CDK4 (0.76) CDK4CCND1HTR2AHTR2CLMNA
SCHEMBL3330892 0.79 CDK4 (0.76) CDK4CCND1HTR2AHTR2CLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577243-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2026-03-17 US disclosed
CN-112457298-B Substituted 2-anilinopyrimidine derivatives and their use as epidermal growth factor receptor modulators 贝达医药公司 2024-05-07 CN disclosed
CN-112375067-B Substituted 2-anilinopyrimidine derivatives and their use as epidermal growth factor receptor modulators 贝达医药公司 2024-03-15 CN disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed
CN-113292557-B Pyridopyrimidinone mesoion derivative containing indole unit and preparation method and application thereof 贵州大学 2022-02-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP CDK4 2330/4885CCND1 3203/4885HTR2A 183/4885
US-12577243-B2 Monoacylglycerol lipase modulators MGLL, LPL, FAAH CDK4 3639/4885CCND1 3908/4885HTR2A 269/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP CDK4 2330/4885CCND1 3203/4885HTR2A 183/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP CDK4 2330/4885CCND1 3203/4885HTR2A 183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.